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ENGLISH SUMMARY 
 
Approximately 20% of the population in Europe suffers from chronic pain and this 
is often treated with opioids or other analgesic drugs. The effect of opioids is 
individual and some people do not respond adequately to treatment and therefore 
pain management is often unsuccessful. More knowledge about the pain processing 
and response to opioids would therefore be beneficial to understand pain and its 
management.  
     The objectives of this PhD thesis were to investigate the pain response to skin 
heat stimulation using a Contact Heat Evoked Potential Stimulator (CHEPS) in 
patients suffering from painful chronic pancreatitis and healthy volunteers, and to 
investigate morphine modulation of the pain response in healthy volunteers.  
     Data were collected from two experimental studies. In study I, central pain 
processing and habituation to CHEPS stimulations in chronic pancreatitis patients 
and in healthy volunteers were assessed using electroencephalography (EEG). In 
study II, the pain response was further investigated in healthy volunteers using EEG 
and magnetic resonance imaging (MRI) obtained by the blood oxygen level-
dependent (BOLD) signal and brain metabolites (spectroscopy). Morphine-induced 
analgesia was further assessed by these three neurophysiological measurement 
methods.  
     The main findings were increased amplitudes of the EEG N2/P2 complex during 
repeated stimuli for chronic pancreatitis patients. This indicates impaired habituation 
as a part of neuroplastic/neuropathic brain changes in chronic pain. On the other 
hand, expected habituation (decreased amplitudes) was observed for healthy 
volunteers. In healthy volunteers the BOLD signal revealed pain-induced activation 
in the anterior cingulate cortex, secondary somatosensory cortex/insula cortex, 
thalamus and cerebellum. Pain stimulation induced an increase in the brain 
metabolite N-acetylaspartate/creatine ratio in anterior cingulate cortex. Following 
morphine treatment, low frequency oscillations in the EEG decreased, whereas high 
frequency oscillations increased. Morphine reduced pain-induced BOLD activation 
in the insula cortex, anterior cingulate cortex and inferior parietal cortex and the 
brain metabolite concentrations of glutamate/creatine, myoinositol/creatine and N-
acetylaspartate/creatine ratios decreased in anterior cingulate cortex. 
    In conclusion CHEPS-induced changes in pain responses before and after 
treatment with morphine were detectable by EEG, the BOLD signal and 
spectroscopy. Despite limitations of the designs, the presented modalities were 
useful to investigate mechanisms of pain and analgesics. Knowledge from more 
modalities may enhance our understanding of the complex mechanisms in chronic 
pain and plays an important role in development of new drugs and optimisation of 
treatment strategies of chronic pain. 
 
 VII 
DANSK RESUME 
Omkring 20% af befolkningen oplever kroniske smerter, og disse bliver ofte 
behandlet med stærkt smertestillende morfinlignende stoffer (opioider). Den 
smertelindrende effekt af opioider er meget individuel, og en del personer har ingen 
eller kun begrænset effekt af opioider. Derfor er smertebehandling ofte 
utilstrækkelig. Mere viden om smertesystemets funktion vil være gavnlig for at 
kunne optimere og individualisere smertebehandlingen hos den enkelte patient. 
     Formålene med dette ph.d.-projekt var at undersøge smerteresponset på 
stimulering med varme på huden ved brug af en kontakttermode (kaldet CHEPS) 
hos patienter med kronisk bugspytkirtelbetændelse og hos raske forsøgspersoner, 
samt at undersøge morfineffekten på smerteresponset hos raske forsøgspersoner.  
     Data fra to eksperimentelle studier blev inkluderet i dette projekt. Den centrale 
smerteprocessering og habituering udløst af CHEPS stimuli blev i studie I undersøgt 
med elektroencephalografi (EEG) hos patienter med kronisk 
bugspytkirtelbetændelse og raske forsøgspersoner. I studie II blev smerteresponset 
yderligere undersøgt både med EEG og magnetisk resonans billeddannelse (MRI), 
hvor blood oxygen level-dependent (BOLD) responset, og metabolitkoncentrationer 
i hjernen (spektroskopi) blev målt. Morfins smertestillende effekt blev ligeledes 
undersøgt med disse tre neurofysiologiske målemetoder.   
     Hovedresultaterne viste en øgning i amplituderne af EEG N2/P2 komplekset ved 
gentagne stimuli hos patienter med kronisk bugspytkirtelbetændelse, hvilket 
indikerer nedsat habituering som et udtryk for neuroplastiske/neuropatiske 
ændringer i hjernen. Som forventet faldt amplituderne (intakt habituering) af EEG 
N2/P2 komplekset hos raske forsøgspersoner ved gentagne stimuli. Hos raske 
forsøgspersoner viste BOLD responset ved smertestimulering aktivering i anterior 
cingulate cortex, sekundær somatosensory cortex/insula, thalamus og cerebellum. 
Smertestimulering viste desuden øgning i N-acetylaspartat/kreatin ratio i anterior 
cingulate cortex. Morfinbehandling nedsatte lavfrekvent aktivitet og øgede 
højfrekvent aktivitet i hjernen målt med EEG, reducerede det smerteinduceret 
BOLD respons i insula cortex, anterior cingulate cortex and inferior parietal cortex, 
og et fald i metabolit ratioer blev fundet for glutamat/kreatin, myoinositol/kreatin og 
N-acetylaspartat/kreatin i anterior cingulate cortex. 
     Det var således muligt at måle CHEPS-inducerede ændringer af smerteresponset 
ved brug af EEG og MRI ved at måle BOLD responset og metabolitkoncentrationer 
i hjernen før og efter behandling med morfin. Trods metodemæssige begrænsninger 
er de præsenterede metoder brugbare til at undersøge mekanismerne bag smerte og 
smertestillende behandlinger. Kombination af information fra flere målemetoder er 
vigtig for at øge vores viden om smertenetværkets komplekse funktion, hvilket i 
fremtiden kan spille en vigtig rolle i udviklingen og valideringen af nye typer 
smertebehandling.      
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CHAPTER 1. INTRODUCTION 
Pain is defined by The International Association for the Study of Pain (IASP) as “an 
unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage” (Merskey, 1994). Acute pain 
arises suddenly and is usually treatable, whereas chronic pain persists over time and 
treatment can be challenging. Pain lasting for periods longer than three month is 
often defined as chronic pain. Chronic pain is a major problem (Breivik, Collett, 
Ventafridda, Cohen, & Gallacher, 2006; Trescot, Helm, et al., 2008) and 19% of the 
population in Europe suffers from chronic pain (Breivik et al., 2006). Chronic pain 
has not only a health, social and economic impact on individuals, but is also an 
enormous cost for the society (Breivik et al., 2006; Eriksen, Jensen, Sjøgren, 
Ekholm, & Rasmussen, 2003). Chronic pain is often controlled by using opioids or 
other strong analgesic drugs. In Denmark, 12% of persons suffering from chronic 
pain use opioids (Eriksen et al., 2003). Genetic factors influence on opioid efficacy, 
metabolism and adverse effects (Tremblay & Hamet, 2010) and Maier et al. 
reported that 29% of persons with chronic non-malignant pain were non-responders 
to morphine (Maier et al., 2002). Due to the complexity of pain and the individual 
analgesic effect of opioids, the pain management is often inadequate. To identify 
abnormal pain processing and obtain better pain management, identification of 
objective biomarkers of the individual analgesic effects are highly warranted 
(Woolf & Max, 2001; Woolf, 2011). Studies have shown that the pain processing in 
the brain is altered due to opioids, but the opioidergic pathways are inadequately 
explored (Balasubramanian, Morley-Forster, & Bureau, 2006; Sprenger, Berthele, 
Platzer, Boecker, & Tölle, 2005) and further investigations of the pathways from 
the periphery to the brain response to pain and its treatment are highly warranted. 
 
1.1. PAIN PROCESSING 
A complex network of neurons is involved in pain processing. Pain information is 
transmitted from the periphery via primary afferent fibres to the central nervous 
system (CNS). The following sections describe the pain system in a simplified way 
to give an overview of the very complex system from the stimulus is transmitted 
from the periphery to the spinal cord and the supraspinal levels (see Figure 1).  
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1.1.1. THE PAIN SYSTEM 
Sensory receptors (primary afferent fibres) in the periphery, which detect 
potentially dangerous signals, are called nociceptors. Nociceptors are peripheral 
free nerve endings and provide information about the stimulus intensity and 
location (Zhu & Lu, 2010). Nociceptive pain is divided into somatic and visceral 
pain, where somatic pain originates from skin, muscle or bone damage and visceral 
pain originates from internal organs (A. E. Olesen, Andresen, Staahl, & Drewes, 
2012). The focus in this thesis will be on somatic pain.     Primary afferent fibres are 
divided into different types of fibres: Aβ-fibres, Aδ-fibres and C-fibres. Aβ-fibres 
have a large diameter and conduct signals (action potentials) quickly as Aβ-fibres 
are highly myelinated. Aδ-fibres are smaller in diameter, thinly myelinated and 
conduct signals slower than Aβ-fibres. C-fibres are smallest in diameter and 
unmyelinated, thus slowly conducting fibres. (D’Mello & Dickenson, 2008) Most 
nociceptors are C-fibres or Aδ-fibres (Zhu & Lu, 2010). Nociceptors can be specific 
responding to mechanical, thermal or chemical stimuli. Nociceptors which respond 
to more modalities are called polymodal and nociceptors which do not respond to 
any of the modalities are called silent. The silent nociceptors cannot be activated in 
general but only in connection with pathological conditions. (Zhu & Lu, 2010) A 
thermal painful stimulus in hairy skin of the arm leads to a double pain sensation; a 
pricking pain (“first pain”) followed by a burning sensation (“second pain”). The 
“first pain” is mediated by the myelinated Aδ-fibres, thus conducted faster than the 
“second pain”, which is mediated by the unmyelinated C-fibres.  
     The primary afferent fibres terminate at the dorsal horn in the spinal cord and 
project to secondary neurons. The dorsal horn is organised into different 
physiologically distinct layers (laminae I-VI). Nociceptive Aδ-fibres and C-fibres 
mostly terminate in the superficial layer of the dorsal horn (laminae I-II) and the 
deeper laminae are mainly supplied by a smaller number of Aδ-fibres and C-fibres.  
Aβ-fibres mostly terminate laminae III-VI. (Craig, 2003; D’Mello & Dickenson, 
2008) Secondary neurons can be nociceptive specific or Wide Dynamic Range 
neurons. The nociceptive specific neurons respond only to nociceptive stimulation 
mediated by Aδ-fibres and C-fibres. The Wide Dynamic Range neurons respond 
both to innocuous and nociceptive stimulation mediated by Aβ-fibres, Aδ-fibres and 
C-fibres. These neurons are dynamic and respond to the stimulus gradually. 
(Marchand, 2008) Neurotransmitters transmit signals between neurons. Glutamate 
is an important neurotransmitter (among others) at all levels of the nervous system 
(D’Mello & Dickenson, 2008). Signals from secondary neurons are mainly 
transmitted via two different pathways to the thalamus; the spinothalamic (lateral) 
tract transmitting signals to the lateral nuclei of the thalamus and the spinorecticular 
(medial) tract transmitting signals to the medial nuclei of thalamus and the 
brainstem (to e.g., nucleus raphes magnus and periaqueductal grey). Both tracts 
cross immediately in the spinal cord. (Marchand, 2008)  
CHAPTER 1. INTRODUCTION 
15 
     When the signals reach the supraspinal level many cortical regions are involved 
in the perception of pain. The activated regions depend on the particular stimulus 
(D’Mello & Dickenson, 2008). However, the most commonly activated cortical 
regions include the primary somatosensory cortex (SI), secondary somatosensory 
cortex (SII), insula cortex (IC), anterior cingulate cortex (ACC) and prefrontal 
cortex (PFC) (Apkarian, Bushnell, Treede, & Zubieta, 2005). These regions are 
commonly referred to as the “pain matrix” (Fomberstein, Qadri, & Ramani, 2013).  
The different cortical regions play different roles in the pain processing. SI is 
associated with the intensity of the stimulus and SII plays a role in coding the 
intensity of the stimulus (Bornhövd et al., 2002). IC also plays a role in pain 
intensity (Bornhövd et al., 2002; Coghill, Sang, Maisog, & Iadarola, 1999) and it 
can be difficult to dissociate IC from SII (Peyron et al., 2002). ACC has a 
connection with the emotional content of the stimulus and involved in coding of 
stimulus perception (Bornhövd et al., 2002). PFC plays a role in directing attention 
towards the stimulus and has a connection to the working memory processing 
(Bornhövd et al., 2002). However, due to plasticity, modulation of nociceptive 
signals is possible at all levels of the CNS (Marchand, 2008).  
 
 
Figure 1: The somatic sensory system. The nociceptive stimulus is transmitted from the 
periphery (in this example, the skin) via primary afferent fibres, which terminates at the 
dorsal horn (organised into different physiologically distinct layers I-IV) in the spinal cord. 
The signal is then transmitted to secondary neurons and reaches the supraspinal level, where 
many cortical regions are involved in pain processing. PFC: prefrontal cortex, ACC: anterior 
cingulate cortex; IC: insula cortex; SI: primary somatosensory cortex; SII: secondary 
somatosensory cortex; Th: thalamus; PAG: periaqueductal grey; RVM: rostral ventromedial 
medulla.        
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1.1.2. CHRONIC PAIN 
Pain processing is altered in chronic pain disorders and often involves changes in 
the nervous system at different levels. Detailed description of the complex pain 
mechanisms behind chronification and chronic pain are beyond the scope for this 
thesis. Sensitisation of the nervous system plays a role in chronic pain disorders. 
Chronic pain disorders can lead to structural, functional and metabolic changes of 
the CNS (Borsook, 2012; Henry, Chiodo, & Yang, 2011). When the CNS is 
sensitised (central sensitisation), the pain response will be amplified, which leads to 
more pain (hyperalgesia). Studies have shown alterations of the CNS and central 
sensitisation in chronic pain disorders (Woolf, 2011). In this thesis painful chronic 
pancreatitis will serve as a model (prototype disease) for chronic pain (even though 
the initiating pain is visceral of origin). 
Chronic pancreatitis 
Chronic pancreatitis (CP) is a major source of morbidity in the Western world. The 
incidence of CP is approximately 10 per 100,000 inhabitants (Andersen, Pedersen, 
Scheel, & Worning, 1982). Chronic abdominal pain is the most common symptom 
and CP is characterised by progressive destruction of the pancreas tissue with 
significant impairment of exocrine and endocrine functions (Lieb & Forsmark, 
2009). Thus, the origin of pain is considered to be visceral. However, studies have 
shown CNS alterations to play a key role in CP (Frøkjær, Olesen, et al., 2011; 
Frøkjær et al., 2012; Lelic, Olesen, Hansen, Valeriani, & Drewes, 2014). Pain 
management in CP is difficult and it is associated with in impaired psychosocial 
functioning, physical disability, decreased quality of life, hospitalisation and is 
costly for the society (Pasricha, 2012). Opioids are often used in treatment of CP 
but limited effectiveness and undesirable side-effects are common (Paisley & 
Kinsella, 2014). Hence, optimised pain management is highly desirable and more 
knowledge would be beneficial to enhance the understanding of the underlying pain 
mechanisms.   
 
1.2. PAIN MANAGEMENT 
Modulation of the nociceptive signal with the aim to reduce the perception of pain 
can be reached using analgesics. The strategy for analgesic treatment normally 
follows the “pain relief ladder” provided by the World Health Organization (WHO) 
initially formulated for pain relief in cancer patients, where the potency of analgesic 
drugs (non-opioids, weak-opioids and strong opioids) are titrated increasingly until 
pain relief is obtained (WHO, 1996). Opioids are used to control moderate to severe 
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acute pain and chronic pain. Opioids mainly act on the CNS, however, opioid 
receptors are also located in the periphery (Stein et al., 2009; Trescot, Datta, Lee, & 
Hansen, 2008). The term “opioid” is used to describe compounds that activate 
opioid receptors (Trescot, Datta, et al., 2008). Opioid receptors can be activated by 
endogenous opioids or exogenous administrated opioids. Endogenous opioids are 
naturally occurring substances (dynorphins, enkephalins, endorphins) (Gutstein & 
Akil, 2006) and this will not be further described. Morphine is the “gold standard” 
exogenous opioid (Lugo & Kern, 2002) and is described in section 1.2.2. Opioid 
receptors are subdivided into μ-receptors, δ-receptors, κ-receptors and the opioid 
receptor like-1 (ORL1) (Corbett, Henderson, McKnight, & Paterson, 2006; Gutstein 
& Akil, 2006). Most clinical relevant opioids (e.g. morphine) exert the main effect 
on the μ–receptors, thus, the distribution of this receptor type will be in focus in the 
next sections describing this type of opioid receptors at the peripheral, spinal and 
supraspinal levels.    
 
 
1.2.1. OPIOID RECEPTORS 
Peripherally, opioid receptors are located at peripheral sensory nerve terminals. 
Opioid peptides or exogenous opioids bind to opioid receptors and this leads to 
analgesia. (Stein, Schäfer, & Machelska, 2003)  Spinally, opioid receptors are 
localised at the presynaptic and post synaptic sites in the spinal cord dorsal horn 
(Inturrisi, 2002). The superficial laminae I (around the termination of C-fibres) and 
substantia gelatinosa of the dorsal horn mostly contain the highest concentrations of 
opioid receptors and receptors are predominantly located presynaptic on the central 
terminals of the primary afferents but also postsynaptic at the secondary neurons 
and on interneurons. The neurotransmitter release of glutamate (and other 
neurotransmitters) is blocked when opioid receptors are activated, thus leading to 
analgesia (Trescot, Datta, et al., 2008), but other mechanisms are also involved in 
the hyperpolarisation of the neurons. Supraspinally, opioid receptors are found in 
the brain stem, thalamus and cortex (Inturrisi, 2002). The periaqueductal grey and 
rostral ventromedial medulla (both opioid-rich regions) are involved in descending 
control of the nociceptive signal as the periaqueductal grey transmits the 
nociceptive signal to the rostral ventromedial medulla and opioids inhibit the 
nociceptive signal transmitted to the dorsal horn laminae. (Heinricher, Tavares, 
Leith, & Lumb, 2009) Imaging studies have shown especially ACC, IC, PFC and 
thalamus to be opioid-rich regions (Apkarian et al., 2005; Firestone et al., 1996; 
Jones et al., 1991; Petrovic, Kalso, Petersson, & Ingvar, 2002; Zubieta et al., 2005). 
These areas are as mentioned in section 1.1.1 also a part of the “pain matrix”.  
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1.2.2. MORPHINE 
Morphine is a widely used opioid to treat acute and chronic pain. Morphine is a 
naturally occurring compound found in the opium poppy plant (Papaver 
somniferum) and first isolated in 1804. Morphine acts on different levels of the 
nervous system, such as the periphery, spinal cord and brain regions and exerts its 
main effect on the μ-receptors (Inturrisi, 2002). Administration of morphine 
includes oral, rectal, subcutaneous, intravenous, epidural and intrathecal routes. 
However, due to simplicity, convenience and economy oral administration is 
preferred (Donnelly, Davis, Walsh, & Naughton, 2014). Morphine passes the 
blood-brain-barrier (which is the interface between the blood and the brain) slowly 
and only approximately 40 to 50 percent of an oral administered dose of morphine 
reaches the CNS, within 30 minutes to 90 minutes (Trescot, Datta, et al., 2008). The 
elimination half-life is approximately 2 hours (Trescot, Datta, et al., 2008). 
Morphine is mainly metabolised into morphine-6-glucoronide (M6G) (10-15%) and 
morphine-3-glucuronide (M3G) (45-55%). M6G has a certain analgesic effect, 
whereas it is now believed that M3G is inactive such as the other metabolites 
(Christrup, 1997; Trescot, Datta, et al., 2008). Although morphine is widely used in 
the clinic, around 1/3 patients with chronic non-malignant pain are defined as non-
responders to morphine and side-effects are common (Maier et al., 2002). Opioids 
affect mood, rewarding behavior, the respiration system, cardiovascular system, 
neuroendocrine system and gastrointestinal function (Gutstein & Akil, 2006). The 
most common side-effects are sedation, constipation and nausea (Brock et al., 
2012). Knowledge about morphine modulation of central pain processing of the 
nociceptive input may provide further insight into the multiple complex 
mechanisms (Woolf & Max, 2001).  
 
1.3. EXPERIMENTAL PAIN MODELS 
It is difficult to evaluate the analgesic effects in clinical trials because pain has an 
impact on a number of personal factors (e.g. psychological, cognitive and social 
aspects) and is confounded by systemic reactions such as fever and general malaise.  
Furthermore, patients suffering from pain are often treated with different drugs, 
which can also influence pain perception. (Drewes, Gregersen, & Arendt-Nielsen, 
2003) Experimental models are advantageous for evaluating analgesic effects 
because both the experimentally induced pain can be controlled and the evoked 
response can be assessed in detail (Arendt-Nielsen, Curatolo, & Drewes, 2007). 
Pain can be induced electrically, thermally, mechanically and chemically and 
stimulation can be applied in muscles, bones, skin and viscera. Thus, pain intensity, 
duration, frequency, and localisation are parameters, which can be designed and 
controlled by the investigator and psychophysical, behavioural and 
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neurophysiologic responses can be assessed (Arendt-Nielsen, 1997). The pain 
system can also be modulated by e.g. pharmacological intervention. The assessment 
of the pain response and the analgesic effects can be quantified by subjective and 
objective methods.  Subjective methods such as standardised scales and 
questionnaires describe the experience of pain. Objective methods, such as 
electroencephalography (EEG), magnetic resonance imaging (MRI), 
magnetoencephalography (MEG), positron emission tomography (PET) and single 
photon emission computed tomography (SPECT) describe the neurophysiologic 
response to pain. Figure 2 shows the concept of an experimental model.  
 
Figure 2: Illustration of the concept of experimental pain models. The pain system is 
modeled by an experimental painful stimulus (e.g. skin heat stimulation) with a specific pain 
intensity, duration, frequency, and localisation. The pain system can be modulated (e.g. 
pharmalogically) and the evoked response can be assessed using subjective (e.g. standardised 
scales) and objective methods (e.g. electroencephalography and magnetic resonance 
imaging). 
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CHAPTER 2. HYPOTHESES & AIMS 
To investigate the pain system, experimental models were applied using skin heat 
as pain stimulation and morphine for modulation of the pain system. It was 
hypothesised that the electrophysiological (EEG) response of painful skin heat 
stimulation is altered in a patient group suffering from painful chronic pancreatitis 
(CP) compared to healthy volunteers (HV). In HV it was also hypothesised that 
pain stimulation would increase brain activation (the blood oxygen level-dependent 
(BOLD) response) in pain-specific areas and alter concentrations of brain 
metabolites measured by MR spectroscopy (MRS) in ACC. Finally, it was 
hypothesised that morphine-induced analgesia would modulate these 
neurophysiologic variables measured during pain stimulations. Such an objective 
assessment approach would likely provide complementary information in 
understanding pain and cortical analgesic mechanisms. An overview of aims, 
papers and studies (described in the next chapter) are illustrated in Figure 3. 
 
Figure 3: Overview of aims which are investigated in study I (including patients suffering 
from chronic pancreatitis (CP) and healthy volunteers (HV) and study II (including only 
healthy volunteers) presented in papers I-IV. EEG, electroencephalography; BOLD, blood 
oxygen level-dependent; MRS, magnetic resonance spectroscopy. 
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Hence, the aims were: 
 
I. To investigate habituation and the brain’s response to phasic painful skin 
heat stimulation in patients suffering from chronic pancreatitis and in 
healthy volunteers using electrophysiological measurements (paper I). 
 
 
II. To investigate the effect of morphine on heat pain induced sensory 
processing with electrophysiological measurements in healthy volunteers 
(paper II). 
 
 
III. To investigate the blood oxygen level-dependent response induced by 
painful skin heat stimulation and the effect of morphine on this response in 
healthy volunteers (paper III). 
 
 
IV. To investigate the magnetic resonance spectroscopy response induced by 
painful skin heat stimulation and the effect of morphine on this response in 
healthy volunteers (paper IV). 
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CHAPTER 3. MATERIALS & METHODS 
3.1. MATERIALS 
Two studies contributed to this thesis. The studies were approved by the local 
Ethics Committee (reference no. N-20090008MCH (study I) and N-20100046 
(study II)) and conducted according to the Declaration of Helsinki. Study II was 
further approved by the Danish Medicines Agency (reference no. 2612–4319) and 
registered at ClinicalTrials.gov (NCT01245244, EUDRACT no. 2010-020894-17). 
Study II was conducted according to the rules of Good Clinical Practice and 
monitored by the Good Clinical Practice unit, Aarhus University Hospital, 
Denmark. All subjects provided informed consent prior to the experiments. Study I 
was conducted from July 2010 through March 2011 and Study II was conducted in 
the period from November 2010 to April 2012 at the Research Laboratory at Mech-
Sense, Department of Gastroenterology and Hepatology and Department of 
Radiology at Aalborg University Hospital, Denmark. 
 
3.1.1. STUDY I 
Fifteen healthy volunteers and 15 patients diagnosed with painful CP were included 
for study I. None of the healthy volunteers were suffering from pain-related 
diseases or receiving medication. Patients suffering from CP were diagnosed 
according to the Lüneburg diagnostic score (Lankisch et al., 2009). Patients had 
upper abdominal pain corresponding to the Th10 dermatome reflecting the referred 
pain area for pancreas (the “viscerotome”) lasting for more than 3 days per week for 
at least 3 months. Patients on stable opioid medication and patients on non-opioid 
analgesics were included. Exclusion criterias were other acute or chronic pain 
diseases and previous surgery in the stimulation area at Th10.  
 
 
3.1.2. STUDY II 
Study II was a randomised, double-blinded, placebo-controlled cross-over study 
with morphine and consisted of two study arms (now termed study IIa and study 
IIb). Forty healthy volunteers participated in study IIa and 20 of the 40 healthy 
volunteers participated in study IIb. Inclusion criterias were normal blood pressure, 
no history of abuse of alcohol, opioids and other drugs, no history of allergy to 
opioids, no planned treatment or surgery during the study period, no history of pain 
disorders or mental illness, and no intake of analgesic 24 hours prior to the 
experiment. Female subjects used safe contraceptive medication and they were 
investigated in the same phase of the individual menstrual cycle. Subjects were 
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asked to avoid eating and drinking for at least four hours before the experiment. All 
subjects participated in screening session where they received the experimental 
stimuli and they were scanned in the MRI scanner to familiarise them with the 
experimental environment and to reduce anxiety.  
     The overall rationale behind study II was to investigate the modulation of the 
pain response (peripherally, spinally and centrally) by use of morphine. Hence, the 
overall study design consisted of multiple pain tests (skin heat, reflexes, bone and 
muscle pressure, multimodal test of rectum (electrical, heat, pressure), cold pressor) 
and measurements (visual analogue scale (VAS), electromyography, EEG, MRI). 
The total length of each session of study IIa and study IIb was approximately 4 and 
3 hours, respectively. For this thesis only a part of these tests and measurements 
were used and other findings in study II are reported elsewhere (Kristiansen et al., 
2014; Lelic, Olesen, Gregersen, et al., 2014; A. E. Olesen, Brock, Sverrisdóttir, 
Larsen, & Drewes, 2014; Sverrisdóttir et al., 2014). Therefore, only tests 
measurements relevant for this thesis are described further.  
 
3.2. METHODS 
A Contact Heat Evoked Potential Stimulator (CHEPS) was used for thermal skin 
heat stimulation and morphine was used to modulate the pain response. Both 
subjective and objective measurements were applied in both studies to assess the 
evoked response to thermal skin heat stimulation. The subjective experience of pain 
perception was assessed by a standardised scale, the VAS, for both studies. EEG 
was used for objective assessment in study I and study IIa and in study IIb objective 
assessments were obtained using functional MRI (BOLD) and proton magnetic 
resonance spectroscopy (1H-MRS, termed MRS). These methods are described in 
further details in the following sections and Figure 4 shows an overview of the two 
studies.   
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Figure 4: Overview of study I and study II. In study I pain was induced using CHEPS 
(Contact Heat Evoked Potential Stimulator) and EEG (electroencephalography) was 
recorded. In study IIa CHEPS-induced pain before and after administration of morphine were 
also assessed by EEG. In study IIb CHEPS-induced pain before and after administration of 
morphine were assessed by BOLD (blood oxygen level-dependent) signal. These recordings 
included both measurements during rest and pain in a so-called “on-off” paradigm. 
Furthermore, both a resting state condition (no pain stimulation) and a painful condition were 
assessed by MRS (magnetic resonance spectroscopy) before and after morphine 
administration.   
 
3.2.1. CONTACT HEAT EVOKED POTENTIAL STIMULATOR 
Thermal skin stimulations were applied using a Pathway Stimulator (CHEPS, 
Medoc Ltd, Ramat Yishai, Israel) with a thermode activation area of 573 mm
2
. A 
MRI compatible thermode was used in the MRI scanner. The heating rate was 70 
°C/s and the cooling rate was 40 °C/s. Both myelinated Aδ-fibres and unmyelinated 
C-fibres are activated during painful contact heat stimulations (Chen, Niddam, & 
Arendt-Nielsen, 2001; Le Pera, Valeriani, Niddam, Chen, & Arendt-Nielsen, 2002). 
Different stimulation paradigms have been applied using contact heat with variable 
pain intensity, duration, frequency, and localisation depending on the method used 
for assessment of the response (either EEG, BOLD or MRS). Several studies have 
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used phasic stimuli (Chen et al., 2001; Roberts et al., 2008; Valeriani, Le Pera, 
Niddam, Chen, & Arendt-Nielsen, 2002) or tonic stimulation (Brooks, Nurmikko, 
Bimson, Singh, & Roberts, 2002; Kupers, Danielsen, Kehlet, Christensen, & 
Thomsen, 2009; Tran, Wang, Tandon, Hernandez-Garcia, & Casey, 2010), 
stimulation of the hand (Brooks et al., 2002), arm (Chen et al., 2001; Greffrath, 
Baumgärtner, & Treede, 2007; Roberts et al., 2008; Warbrick, Derbyshire, & 
Bagshaw, 2009) or leg (Kupers et al., 2009; Tran et al., 2010; Warbrick et al., 
2009), moving thermode position between stimuli (Greffrath et al., 2007; Roberts et 
al., 2008; Tran et al., 2010; Warbrick et al., 2009) or fixed position (Greffrath et al., 
2007; Warbrick et al., 2009) and different inter-stimulus interval (ISI) (Chen et al., 
2001; Valeriani et al., 2002).  
     We used different stimulation paradigm designs for the different research 
questions in study I and study II. In study I we applied 31 phasic stimuli on the 
forearm and upper abdominal area (as this area, Th10, share spinal segmental 
innervations with the pancreatic gland) with variable ISI (8-12 s) and the thermode 
was moved between stimuli (see paper I for details). This sequence was repeated 
three times at each area. Using phasic stimuli the evoked brain potentials can be 
recorded by EEG (Chen et al., 2001). The advantage of moving the thermode 
slightly between stimuli is that potential local skin habituation or sensitisation can 
be avoided or reduced (Chen et al., 2001; Roberts et al., 2008). The initial idea of 
study II was to design a stimulation paradigm allowing comparison of EEG and 
BOLD results. Thus, we had to compromise the quality of the measured response as 
the two measurement modalities require different set-ups. It was not possible to 
move the thermode inside the scanner during an experiment as the thermode was 
too sensitive to movements. Furthermore, compared to EEG, more blocks of stimuli 
were needed for the stimulation paradigm to obtain an acceptable signal-to-noise 
ratio for the BOLD analysis. Longer and repeated stimulations can likely introduce 
local skin habituation (Kleinböhl, Trojan, Konrad, & Hölzl, 2006). Thus, for study 
IIa (EEG) the stimulation paradigm was designed with only 15 phasic stimuli on the 
forearm with short ISI (1 second) and the thermode was at a fixed location (see 
paper II for further information). For the BOLD analysis in study IIb stimuli was 
delivered on the forearm in 9 blocks with same ISI between stimuli (1 second) 
within a stimulation block (18 seconds in total for one block) with 18 s between 
stimulation blocks (details described in paper III). A tonic stimulation paradigm (5 
minutes) was used for MRS analysis in study IIb as the MRS recording takes 
several minutes. The stimulus was applied to the upper leg (see paper IV for more 
information). A similar design has been used by Kupers et al. (Kupers et al., 2009). 
An overview of the different stimulation paradigms, location and response 
assessment is shown in Table 1. 
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Table 1: Overview of CHEPS paradigms in study I-II, paper I-IV.  
 Study I Study II 
 EEG 
(paper I) 
EEG 
(paper II) 
BOLD 
(paper III) 
MRS 
(paper IV) 
Location Forearm/upper  
abdominal area 
Forearm Forearm Upper leg 
Type Phasic Phasic Phasic Tonic 
Stimuli per sequence 31 15 9 1 
Number of sequences 3 1 9 1 
ISI (s) 8-12 1 1 - 
Thermode position Moved Fixed Fixed Fixed 
Temperature (°C) 51 52 52 Max 45 
ISI: inter-stimulus interval; EEG: electroencephalography; BOLD: blood oxygen level-
dependent; MRS: magnetic resonance imaging. 
3.2.2. MORPHINE 
In study II, morphine and placebo were orally administered (double-blinded) in a 
randomised order. 30 mg of morphine (15 mL morphine oral liquid mixture 2 
mg/mL, The Hospital Pharmacy, Aalborg University Hospital, Denmark) or 
placebo (15 mL placebo solution, The Hospital Pharmacy, Aalborg University 
Hospital, Denmark) was administered. To mask any taste and colour 5 mL orange 
juice concentrate was mixed together with both solutions. Side-effects were 
monitored during both sessions and one day after each session by questionnaire and 
phone interview. The time interval between the two sessions was at least one week 
to allow washout. 
 
3.2.3. PAIN PERCEPTION 
Two different VAS methods were used in study I and study II. Study I was a pure 
pain study whereas analgesia was expected in study II with the possibility of the 
heat stimulus to be perceived as a non-painful sensation after morphine 
administration. Thus, another scale was more suitable for study II. In study I: 0 = no 
pain to 10 = worst pain imaginable. This scale has been used in a similar study 
(Greffrath et al., 2007).  In study II, the pain threshold was set at 5, with the 
following anchor words on the scale: 0 = no sensation; 1 = vague perception of mild 
sensation; 2 = definite perception of mild sensation; 3 = vague perception of 
moderate sensation; 4 = definite perception of moderate sensation; 5 = pain 
detection threshold; 6 = slight pain; 7 = moderate pain; 8 = medium pain; 9 = 
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intense pain; and 10 = unbearable pain. This scale has been validated for reliability 
and robustness in both somatic and visceral pain studies and is described elsewhere 
(Drewes et al., 2003). To support the memory of the VAS inside the scanner, a 
modified electronic VAS was used and operated by the subject inside the scanner 
using control buttons. The modified VAS was displayed in goggles mounted onto 
the head coil as a vertically oriented scale with numbers 0-10 and anchor word at 
values 0, 5 and 10. 
  
3.2.4. ELECTROENCEPHALOGRAPHY 
EEG provides an objective method to study altered central pain processing and has 
proven to be a useful method to study analgesic effects (Knott, 2000; Malver et al., 
2014). EEG has high temporal resolution but poor spatial resolution. Electrical 
activity is generated in the brain by neuronal firing within the brain and this 
electrical activity can be measured by EEG. In a resting state condition 
(spontaneous EEG), the neuronal firing is randomly distributed in time, but this 
neuronal firing can be synchronised and activated sequentially when an external 
stimulus is applied (such as short heat pulses induced by the CHEPS). The latter is 
called brain evoked potentials (EPs). The resting state EEG have been used to 
describe abnormal CNS processing in chronic pain patients (S. S. Olesen, 
Graversen, et al., 2011; S. S. Olesen, Hansen, et al., 2011) and altered pain 
processing during pharmacological intervention (Knott, 2000) but this will not be 
described further in this thesis. EPs are typically quantified by their peak latencies 
and amplitudes, power spectrum, scalp topographies and brain source localisation. 
EPs have also been used to study altered brain response to pain stimulation 
(Blauenfeldt, Olesen, Hansen, Graversen, & Drewes, 2010; Frøkjær, Egsgaard, et 
al., 2011; Valeriani, Pazzaglia, Cruccu, & Truini, 2012) and during 
pharmacological intervention (Staahl et al., 2011). Traditional EP analysis is typical 
performed as an average procedure of the EEG response to several repeated stimuli 
in the time domain. Thus, the signal-to-noise ratio is improved (Dawson, 1951). 
However, this procedure cancels out non-phase-locked signals and is therefore 
mostly valid when the main evoked components are phase-locked. In study I the 
traditional average procedure was applied and peak latencies and amplitudes of the 
main components of the EPs were assessed (paper I). As described in section 3.2.1 
the stimulation paradigm was slightly different in study II and more latency 
variation (jitter) among sweeps was present (see Figure 5). Thus, a more advanced 
analysis was used. Previously, studies have extracted information from EPs using 
single-sweep analysis of EPs in the frequency domain rather than the time domain 
in diabetes mellitus patients (Graversen, Frøkjaer, Brock, Drewes, & Farina, 2012) 
and in assessment of the analgesic effect of buprenorphine and fentanyl (Gram et 
al., 2013). Thus, inter-trial phase alignment and phase-resetting properties of the 
EPs are preserved (Digiacomo, Marco-Pallarés, Flores, & Gómez, 2008). In study 
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IIa single-sweep analysis of EPs was used to identify alterations induced by 
morphine (paper II). 
 
 
Figure 5: Single-sweeps (black) and the corresponding average evoked potential (red). An 
example of CHEPS evoked potentials from study I (top) and study IIa (bottom). The two 
main peaks (N2 and P2) of the average evoked potentials are present in both signals around 
400 ms and 500-520 ms after stimulus onset, respectively. More latency variation (jitter) is 
present in the recording from study IIa illustrated in the bottom figure.  
 
3.2.5. MAGNETIC RESONANCE IMAGING 
In experimental pain models, MRI can be used to image brain structures (e.g. 
diffusion tensor imaging (DTI) tractography, volumetry, grey matter density), 
functional brain activity (e.g. BOLD, arterial spin labeling (ASL)) and MRS. MRI 
reveals a high spatial resolution and allows non-invasive and non-radioactive 
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assessment. Only BOLD and MRS, the methods used in Study IIb, are described 
further.  
     Functional MRI is widely used to estimate brain activity and is typically 
obtained from the BOLD signal where changes in the hemodynamic response are 
measured. Increased neuronal firing requires increased oxygen level and the blood 
flow and volume are increased to deliver more oxygen. Oxygenated blood displaces 
deoxygenated blood a few seconds after neural activity is increased. Oxygenated 
blood and deoxygenated blood have different magnetic properties as oxygen is 
carried by hemoglobin in the blood and oxygenated hemoglobin is less magnetic 
(diamagnetic) than deoxygenated hemoglobin (paramagnetic). Thus, changes in this 
relationship can be detected using an MRI scanner. The BOLD signal (see Figure 6) 
can for instance be modulated by experimental thermal noxious stimuli (Brooks et 
al., 2002; Helmchen et al., 2008; Roberts et al., 2008) and pharmacological 
intervention (Becerra, Harter, Gonzalez, & Borsook, 2006; Gear et al., 2013; 
Wanigasekera et al., 2012; Wise et al., 2002). CHEPS-induced pain was used to 
investigate the brain response before and after morphine administration (paper III).  
 
Figure 6: An example of brain activation during CHEPS stimulation. Activity is seen in the 
anterior cingulate cortex and insula cortex/secondary somatosensory cortex. L: left; R: right. 
Proton magnetic resonance spectroscopy (1H-MRS, termed MRS in this thesis) is a 
method for measurement of brain metabolite concentrations in vivo such as N-
acetylaspartate, glutamate, glutamine, choline, creatine, myoinositol, γ-
aminobutyric acid (GABA). MRS can also be used to measure metabolite 
concentrations in other tissue than the brain and MRS can be obtained from 
different nuclei than protons, but this will not be explained in this thesis. MRS is 
widely used in the brain because of high sensitivity and abundance. Protons in 
different molecules resonate at different frequencies, which results in a small 
chemical shift when a magnetic field is applied. Thus, a MR spectrum is obtained 
(see Figure 7) with metabolites appearing at specific ppm (parts per million). The 
area under the curve refers to the metabolite concentration. (Fayed, Olmos, 
Morales, & Modrego, 2006) Assessment of brain metabolites using MRS have been 
used in experimental studies in healthy volunteers during acute pain stimulation 
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(Gussew et al., 2010; Gutzeit et al., 2011, 2013; Kupers et al., 2009; Mullins, 
Rowland, Jung, & Sibbitt, 2005) and brain metabolite concentration changes has 
been investigated in long-term opioid dependent subjects (Haselhorst et al., 2002; 
Yücel et al., 2007). We investigated MRS in the ACC in response to pain and 
morphine administration.   
 
Figure 7: Example of MRS spectrum with a 2×2×2 cm single voxel placed in anterior 
cingulate cortex. Only relevant metabolites for this thesis are presented in the figure. mI, 
myoinositol; cre, creatine; glu, glutamine; NAA, N-acetylaspartate; ppm, parts per million. 
  
3.2.6. STASTITICAL ANALYSES 
Different analyses approaches were used for the specific EEG, BOLD and MRS 
related outcomes and the statistical analyses of the studies are reported in details in 
paper I-IV. As the studies could be considered as explorative studies including 
multiple end-points, exact sample size calculations were difficult. As a common 
approach, the subjective pain perception (VAS) was included in all the studies. 
Considering the change in VAS rating as an outcome, and including knowledge 
from our previous CP patient and pharmacology intervention studies, it was realistic 
to set the minimal detectable difference between groups to 25% of the mean VAS 
and the standard deviation of the mean to 25%. Based on this effect size, this 
resulted in 16 subjects per group (alpha=0.05, power=0.80) using a two-sided t-test. 
Additionally, previous studies, which assessed the analgesic effects have typically 
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included 10-20 subjects for EEG analysis (Malver et al., 2014) and 8-13 subjects 
for BOLD analysis (Becerra et al., 2006; De Simoni et al., 2013; Gear et al., 2013; 
Wise et al., 2002). The literature is more limited for MRS assessment of the opioid 
effects in healthy volunteers. Thus, many factors can influence the size of the 
required sample and the above mentioned considerations and feasibility 
considerations were taken into account to decide the sample sizes.     
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CHAPTER 4. RESULTS 
The key results from the studies are presented in this chapter. More detailed results 
are found in paper I-IV. An overview of the results is illustrated in Figure 8. 
 
4.1. AIM I 
Aim: To investigate habituation and the brain’s response to phasic painful skin heat 
stimulation in patients suffering from chronic pancreatitis and in healthy volunteers 
using electrophysiological measurements (paper I). 
Key results:  
 N2/P2 amplitudes increased 25% in CP patients and decreased 20% in HV 
during repeated pain stimulation in the referred pancreatic area (Th10 
dermatome; P = 0.006). 
 N2/P2 amplitudes increased 3% in CP patients and decreased 20% in 
HV during repeated pain stimulation of the forearm (P = 0.06).   
 N2/P2 amplitudes were unchanged in CP patients (F = 2.0; P = 0.2) and 
decreased in HV (F = 4.6; P = 0.02) during the second and third sequences 
of stimulation of the referred pancreatic area (Th10 dermatome).  
 N2/P2 amplitudes were unchanged in CP patients (F = 2.0; P = 0.8) and 
decreased in HV (F = 4.1; P = 0.04) during the second and third sequences 
of stimulation of the forearm.  
 
Interpretation: Patients suffering from CP revealed impaired habituation, whereas 
HV showed habituation to repeated pain stimulation as expected. Thus, altered 
central pain processing was demonstrated in CP patients. 
 
4.2. AIM II 
Aim: To investigate the effect of morphine on heat pain-induced sensory processing 
with electrophysiological measurements in healthy volunteers (paper II). 
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Key results: 
 Compared with placebo, morphine decreased the spectral indices in the 
delta and theta bands during pain stimulation by 13% (P = 0.04) and 9% 
(P = 0.007), respectively. 
 Compared with placebo, morphine increased the spectral indices in the 
beta and gamma bands during pain stimulation by 10% (P = 0.006) and 
24% (P = 0.04), respectively. 
 
Interpretation: Decreased low frequency and increased high frequency oscillations 
in indicate diminished pain response in response to morphine treatment. 
 
4.3. AIM III 
Aim: To investigate the blood oxygen level-dependent response induced by painful 
skin heat stimulation and the effect of morphine on this response in healthy 
volunteers (paper III). 
Key results:  
 Pain stimulation induced activation in the anterior cingulate cortex, 
secondary somatosensory cortex/insula, thalamus and cerebellum              
(P < 0.05). 
 In response to morphine treatment the spatial extent of the activated pain 
specific areas decreased.  
 Reduced pain-induced activation was seen in the right insula, anterior 
cingulate cortex and inferior parietal cortex after morphine treatment 
compared to before treatment (P < 0.05).  
 No effect on pain-induced brain activation was seen after placebo 
treatment compared to before treatment (P > 0.05). 
 
Interpretation: Brain areas of the “pain matrix” were activated by pain stimulation 
and morphine reduced activation in pain specific and opioidergic dominant areas.     
 
4.4. AIM IV 
Aim: To investigate the magnetic resonance spectroscopy response induced by 
painful skin heat stimulation and the effect of morphine on this response in healthy 
volunteers (paper IV). 
 
CHAPTER 4. RESULTS 
35 
Key results:  
 Pain stimulation induced an increase in N-acetylaspartate/creatine ratio        
(F = 5.5, P = 0.04) in ACC. 
 During morphine treatment painful stimulation induced decreased 
glutamate/creatine (F = 7.3, P = 0.02), myoinositol/creatine (F = 8.38, P = 
0.02) and N-acetylaspartate/creatine ratios (F = 13.8, P = 0.004). 
 During placebo treatment pain stimulation induced an increase N-
acetylaspartate/creatine ratio (F = 6.1, P = 0.04).  
Interpretation: N-acetylaspartate/creatine ratio increased during pain and 
decreased during morphine treatment together with decreased levels of 
myoinositol/creatine and glutamate/creatine. Thus, these metabolites may play a 
role in pain processing and opioid-induced analgesia.  
 
Figure 8: Overview of results of the two studies divided by papers and aims. EEG, 
electroencephalography; BOLD, blood oxygen level-dependent; MRS, magnetic resonance 
spectroscopy; ↑, increase; ↓, decrease; →, unchanged; seq., sequence; CP, chronic 
pancreatitis; HV, healthy volunteers; ACC, anterior cingulate cortex; SII, secondary 
somatosensory cortex; IC, insula cortex; IPC, inferior parietal cortex; NAA, N-
acetylaspartate; mI, myoinositol; glu, glutamate; cre, creatine.   
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CHAPTER 5. DISCUSSION 
CHEPS stimulations were used to investigate the pain system in patients with CP 
and HV, and morphine was administered to modulate the pain system in HV. The 
pain response was assessed by EEG, BOLD and MRS. The first part of the 
discussion contains methodological considerations regarding these elements for 
modeling, modulation and assessment of the pain system, followed by a discussion 
of the actual pain and morphine response found by these different modalities. 
  
5.1. METHODOLOGICAL CONSIDERATIONS 
CHEPS stimulations 
Different settings of the CHEPS were used in the two studies to evoke painful 
stimulations. CHEPS stimulation introduced habituation. In study I (paper I) the 
stimulation paradigm was designed to evoke habituation during repeated sequences 
of stimuli, whereas this was not the case for study II.  Due to habituation it was 
difficult to provide stimuli which were painful during the entire stimulation period 
(as seen in paper III). Higher stimulation temperatures were not possible, as this 
would increase the risk of skin injury. Local skin habituation is introduced much 
faster when stimulating the same skin area compared to the use of variable locations 
(Greffrath et al., 2007). Local skin habituation could have been minimised by 
moving the thermode between each stimulation (as mentioned in section 3.2.1, this 
was not practically possible inside the scanner as the thermode was highly sensitive 
to movements) and central habituation would still be present as repeated blocks of 
stimulations were required (paper III). An event-related design with long and 
variable ISI could also have been used to minimise central habituation and this 
would be preferable for future studies as fewer stimuli are required. A similar 
design with long and variable ISI would be possible for EEG recordings of evoked 
potentials (paper II), however, with long ISI, this is more time consuming and was 
not possible for the present study. Even though habituation was present, we showed 
activation of the “pain matrix” and hence the use of slightly different CHEPS 
paradigms (dictated by the individual setup of the studies) was able to evaluate 
different aspects of pain processing.  
     Other parameters such as anticipation, attention and anxiety also influence the 
individual pain perception. Anticipation can be minimised with variable ISI. 
Attention confounders were minimised as subjects were asked to count the number 
of stimuli to keep attention at a constant level. Furthermore, subjects participated in 
a screening session in study IIa and study IIb before the actual experiment to reduce 
anxiety.   
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Morphines effects 
The dose (30 mg) and administration (oral) of morphine in this study was chosen 
based on experience from previous studies (A. E. Olesen, Staahl, Arendt-Nielsen, & 
Drewes, 2010; Staahl, Christrup, Andersen, Arendt-Nielsen, & Drewes, 2006). A 
dose of 30 mg morphine is clinically relevant, and avoids too many gastrointestinal 
side-effects such as nausea, vomiting, feeling of euphoria. In paper II-IV only 
limited morphine effect was demonstrated on pain perception during CHEPS 
stimulations. This can be due to several reasons. 1) The inter-individual variability 
in analgesic effect (Rakvåg et al., 2005; Staahl, Olesen, Andresen, Arendt-Nielsen, 
& Drewes, 2009). Thus, the response from non-responders (which could me more 
than 30% in healthy volunteers) might blur the true analgesic effect as group-level 
analyses were performed. 2) A single oral dose of morphine was administered, and 
the individual time to reach the maximal analgesic effect is variable. Thus, the 
optimal time point for measuring varies, but measurements were assessed at the 
same time point (60 minutes after administration for EEG and BOLD and 80 
minutes after administration for MRS) for all subjects. The onset of analgesia is 
typically 30-40 min after oral morphine administration and the duration is 4 hours 
(Bennett et al., 2005). Blood samples were collected at several time points in study 
IIa (this was not feasible in study IIb) and maximum plasma concentration of 
morphine was found 45 minutes after administration (Sverrisdóttir et al., 2014). 
Thus, the maximum morphine concentration in the brain was reached after this time 
point. 3) Habituation also affects the pain perception but this has already been 
discussed. 4) Opioids may in some cases cause hyperalgesia (however not typically 
after a single dose) and this may confound the results together with other effects 
such as sedation (Khodayari-Rostamabad et al., 2015). 5) It can also be speculated 
that contact heat might not be the optimal type of stimulation as it has been 
demonstrated that deeper and tonic stimulations are more sensitive to morphine 
analgesia (Staahl et al., 2009). However, CHEPS stimulation was chosen to detect 
changes in objective measurements. 6) Higher doses, repeated doses or other 
administration routes of morphine might be more effective to reveal changes in 
behavioral and perhaps the objective measurements. However, higher doses may 
lead to side-effects and high dropout rates. 7) Finally, sample size could be the 
limiting factor. Previously, studies demonstrated analgesic effect of this dose of oral 
morphine in 24 subjects (A. E. Olesen et al., 2010; Staahl et al., 2006) and the 
limited effect on pain perception could be due to the low number of subjects 
included in paper III-IV and future analysis should include more subjects.  
 
Electroencephalography analysis 
In paper I we used the traditional averaging procedure of EPs, which has been used 
in several other studies (Chen et al., 2001; Valeriani et al., 2002). This procedure 
was not suitable for EP analysis in paper II due to lower EP amplitudes and latency 
variability (jitter) as shown in Figure 5 (jitter) as shown in Figure 5. Low EP 
amplitudes were expected due to peripheral habituation as the thermode position 
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was fixed. Greffrath et al. compared pain ratings and EP amplitudes of CHEPS-
evoked noxious stimuli with variable thermode location between stimuli, similar to 
the study design in paper I and with fixed thermode location. They found the last 
three pain ratings to be reduced by 40% and 70% compared to the first pain rating 
for variable and fixed thermode location, respectively. Furthermore, the normalised 
EP amplitudes were decreased 10% and 50% across the first three stimuli. For this 
reason, we only recorded 15 stimuli at fixed location (paper II). They also 
concluded that pain ratings and EP amplitudes were reduced using fixed location as 
compared to variable location corresponding to a reduction of 5°C in stimulus 
temperature. (Greffrath et al., 2007) A recent study, published after conduction of 
these studies, demonstrated that latency jitter can be reduced by shortening of the 
stimulus duration (e.g. by stimulating with a higher baseline temperature) resulting 
in a more synchronised recruitment of afferents (Kramer, Haefeli, Jutzeler, Steeves, 
& Curt, 2013). Temperature rise time and the level of contact with the thermode are 
possible parameters with can affect latency jitter (Warbrick et al., 2009). Using the 
single-sweep analysis changes in latency jitter can be disclosed and studies 
suggested single-sweep analysis approach to be superior to the traditional averaging 
procedure (Hu et al., 2011; Hu, Mouraux, Hu, & Iannetti, 2010; Mayhew, Iannetti, 
Woolrich, & Wise, 2006; Warbrick et al., 2009). 
     EPs are often cleaned to remove noisily sweeps or details containing e.g. eye 
blinks, external noise, ect. Realignment of sweeps is also a way to keep information 
of amplitudes, but physiologically relevant information may be lost in these 
procedures. EPs (paper II) were thoroughly investigated in the traditional time 
domain before performing the single-sweep analysis in the frequency domain. We 
applied several manual, semi-automated and automated methods (e.g. the method 
by Hu et al. (Hu et al., 2010)) to the data in paper II, but they were not suitable to 
extract valid results. Besides requirement of data quality testing, the single-sweep 
analysis approach in paper II was fully automated and included all recorded sweeps, 
which makes the method objective, robust to noise, inter-observer independent and 
less time-consuming than other semi-automated and automated methods.  
     As written in Section 3.2.4 electrical brain activity is not only reflected in EPs 
but also in the spontaneous (resting state) EEG. The spontaneous EEG is obtained 
during a resting condition (with no stimulation involved) or tonic painful 
stimulation. Spontaneous EEG has been used to identify altered pain processing in 
chronic pain patients and during pharmacological intervention. Challenges of 
stimulus confounders are avoided in the resting state EEG method. However, 
different information is extracted and resting state EEG could be suggested a 
supplementary method to EP analysis. A major difference between resting state 
EEG and EPs is that a non-pain specific state is measured in the resting state 
generated by neuronal firing and reflects a mix of several brain regions working 
together.  
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Blood oxygen level-dependent signal analysis  
As previously discussed habituation was present during repeated blocks of stimuli. 
To account for this, pain intensity ratings were included in the analysis model. 
However, only habituation between block was considered in the model. The pain 
response within each block was not totally stable as assumed using a boxcar model, 
and thus, the model fit was not optimal. This might influence the ability to detect a 
large significant drug effect. A robust difference in response to morphine treatment 
might be masked by a maybe larger individual habituation component. Study III 
was an explorative study and due to incomplete data and the low number of subject, 
who had all recordings necessary for a two-way repeated measures ANOVA 
analysis, different numbers of subjects were included for t-test analysis of morphine 
and placebo effect. Similar statistics have been used in other designs (Borras et al., 
2004; Kim et al., 2013; Wanigasekera et al., 2012), but for a non-explorative study, 
it would be ideal to demonstrate a 2x2 interaction for both imaging data and the 
behavioral data to reveal a robust drug effect.  
     Using a task-related experiment as in paper III it is difficult to control for inter-
subject variations in stimulus perception. This can be avoided by measuring brain 
activity in a resting state condition. Resting state functional MRI (fMRI) is a task-
free measurement of the functional connectivity between brain areas reflecting 
synchronous slow frequency oscillations and has previously been used in 
pharmacological studies (Becerra et al., 2006; Gear et al., 2013; Khalili-Mahani et 
al., 2012).   
 
Magnetic resonance spectroscopy analysis 
Analysis of brain metabolite concentrations in the ACC was performed as ratios to 
creatine, which have been done previously (Feraco et al., 2011; Yabuki, Konno, & 
Kikuchi, 2013).  It would also be possible to estimate absolute values of metabolite 
concentrations to obtain a more direct measurement of changes. However, a more 
comprehensive analysis is needed including e.g. tissue segmentation as the voxel of 
interest is a mix between white matter, grey matter and cerebral spinal fluid 
together with relaxation correction. For data analysis in paper IV other bias was 
possible, such as prior task hangover and between-days variability, which might 
blur the true absolute metabolite concentration levels. Thus, we used ratios. MRS 
was measured in the ACC, but it could be interesting to investigate MRS in these 
other brain regions which were found relevant in the BOLD analysis. Chemical 
shift imaging (allowing multi voxel spectroscopy) would be a method to investigate 
metabolite concentrations in several brain areas, but the signal-to-noise ratio is 
normally reduced considerably and the acquisition time will typically be too long 
for investigation the response to a pain stimulus (Jansen, Backes, Nicolay, & Kooi, 
2006).  
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5.2. PAIN RESPONSES 
Electrophysiological response 
Decreased habituation to noxious stimuli might be related to increased activation of 
sensory CNS pathways. Decreased habituation have been reported in other chronic 
pain disorders, such as migraine, fibromyalgia and cardiac syndrome X (de 
Tommaso et al., 2011; Valeriani et al., 2003, 2005). The findings in paper I 
corresponds to previous findings in EEG and MRI studies supporting central 
neuroplastic changes in painful CP (Frøkjær et al., 2012; Frøkjær, Olesen, et al., 
2011; Lelic, Olesen, Hansen, et al., 2014). Pain is complex and exists of sensory, 
cognitive and affective components, and therefore, involves physical and 
psychological aspects of the stimulus. Results from paper I revealed decreased 
N2/P2 amplitudes (habituation) for HV during repeated sequences of stimulation, 
whereas N2/P2 amplitudes were increased or unchanged (decreased habituation) for 
CP patients. The N2/P2 response is mainly related to insula and cingulate cortex 
activity (Garcia-Larrea, Frot, & Valeriani, 2003), which has a strong association 
with the emotional and affective components of pain. It could be interesting to 
investigate whether increased activity and metabolite changes in insula and ACC 
can be detected for pain patients using fMRI and MRS. Future MRI studies in 
painful CP should include such assessments.  
 
 
 
Blood oxygen-level dependent response 
Increased levels of CHEPS-induced BOLD activation were found in areas involved 
in pain processing; ACC, SII/IC, Th and the cerebellum (paper III). Previously 
studies on heat pain have shown similar activation including more or less identical 
activated areas, see Table 2 As discussed previously the perceived stimuli were not 
painful during the entire stimulation period. Innocuous and noxious heat 
stimulations has been investigated in previous studies (Becerra et al., 1999; Brooks 
et al., 2002; Moulton, Pendse, Becerra, & Borsook, 2012; Tseng, Tseng, Chao, Lin, 
& Hsieh, 2010) and some pain-specific areas can be activated for both innocuous 
and noxious stimuli and others only for noxious stimuli. Tseng et al. reported the 
anterior IC, ACC and Th to be activated for both innocuous and noxious stimuli 
among other areas (e.g. the cerebellum) and the SI, SII and posterior IC to be 
activated only following noxious stimuli (Tseng et al., 2010). Hence, the measured 
BOLD response in the ACC and SII/IC might be enhanced with a more consistent 
stimulus and other pain-specific areas as the SI and PFC might also be activated.  
 
 
 
 
 
Table 2: Examples of heat pain studies in healthy volunteers induced by contact heat.  
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Authors N Paradigm Thermode 
position 
Results 
(Quiton, Keaser, 
Zhuo, Gullapalli, & 
Greenspan, 2014) 
 
14 Tonic Fixed ↑ pACC, aMCC, aIC, SII 
↓ SI, frontal lobe 
(Moulton et al., 
2012) 
16 Tonic Fixed ↑ ACC, IC, supramarginal gyrus, 
angular gyrus, superior parietal 
lobule, frontal gyrus, thalamus, 
primary motor cortex, SII 
(Shenoy et al., 
2011) 
12 Phasic Moved ↑ post-central gyrus, IC, MCC, 
frontal gyrus, cerebellum, 
thalamus 
(Tran et al., 2010) 14 Tonic Fixed ↑ pACC, IC, orbito frontal, 
prefrontal, thalamus, inferior 
parietal lobule, SI 
(Tseng et al., 2010) 12 Tonic Fixed ↑ SI, SII, IC, PMA, frontal gyrus, 
cerebellum, SMA, thalamus, 
lentiform nucleus, midbrain 
(Staud, Craggs, 
Perlstein, Robinson, 
& Price, 2009) 
 
13 Phasic Fixed ↑ ACC, IC, thalamus, SI, SII 
(Roberts et al., 
2008) 
10 Phasic Moved ↑ IC, post-central gyrus, SMA, 
MCC, pre-central gyrus 
 
(Brooks et al., 2002) 18 Tonic  Fixed ↑ IC, ACC, SII, cerebellum, 
frontal gyrus 
 
(Apkarian, Gelnar, 
Krauss, & 
Szeverenyi, 2000) 
7 Tonic Fixed ↑ IC/SII, PM/MI, SI 
↓ SMA, CC, PM/MI, posterior 
parietal cortex 
(Becerra et al., 
1999) 
12 Tonic Fixed ↑ Frontal gyrus, ACC, PCC, 
thalamus, motor cortex, SI, SII, 
SMA, IC, cerebellum 
Studies are listed in descending order based on year published. N: number of subjects; ↑: 
increased activation; ↓: decreased activation; pACC: pregenual anterior cingulate cortex; 
aMCC: anterior midcingulate cortex; aIC: anterior insula cortex; SII: secondary 
somatosensory cortex; SI: primary somatosensory cortex; ACC: anterior cingulate cortex; 
IC: insula cortex; MCC: middle cingulate cortex; PMA: premotor area; SMA: 
supplementary motor area; PM/MI: premotor and primary motor regions; PCC: posterior 
cingulate cortex; Phasic refers to brief heat pulses. Stimuli with duration of at least several 
seconds are here called tonic. This stimulus is typically repeated in the “on” periods of “on-
off” paradigms.   
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Magnetic resonance spectroscopy response 
N-acetylaspartate/creatine increased in response to CHEPS stimulation. Increased 
brain activity reflects an increase in neuronal energy demand which is thought to 
reflect enhanced glutamate neurotransmission (Magistretti & Pellerin, 1999). We 
did not find changes in glutamate (paper IV), which is consistent with Kupers et al., 
who investigated metabolite changes in the rostral ACC following painful tonic 
heat stimulation (Kupers et al., 2009). On the other hand, other studies in acute pain 
found increased levels of glutamate in IC and ACC (Gussew et al., 2010; Mullins et 
al., 2005). Physiological mechanisms responsible for the changes in brain 
metabolite concentrations in response to acute pain are not well described. N-
acetylaspartate is a neuronal and axonal marker and involved in neuronal 
metabolism (Castillo, Kwock, Scatliff, & Mukherji, 1998; Clark et al., 2006; Manji, 
Moore, Rajkowska, & Chen, 2000; Moffett, Ross, Arun, Madhavaroa, & 
Namboodiri, 2007; Tsai & Coylet, 1995). N-acetylaspartate is synthesised within 
the mitochondria. Reduced levels of N-acetylaspartate are correlated with a 
decrease in adenosine triphosphate and oxygen consumption (Manji et al., 2000; 
Tsai & Coylet, 1995) and N-acetylaspartate is suggested to be a reservoir of 
glutamate (Clark et al., 2006). Thus, an increase in N-acetylaspartate/creatine might 
be explained by the role of N-acetylaspartate in neuronal metabolism, and changes 
in N-acetylaspartate and glutamate could be related in a complex metabolic way. 
Thus, this could theoretically explain different observations between studies in 
glutamate and N-acetylaspartate, depending on the exact setup and conditions.  
 
 
5.3. MORPHINES EFFECTS 
Electrophysiological response 
Decreased oscillations in low frequency bands (delta 0.5-4 Hz and theta 4-8 Hz) 
and increased oscillations in high frequency bands (beta 12-32 Hz and gamma 32-
80 Hz) during heat stimulation were found after morphine treatment compared to 
placebo (paper II). In paper I, N2 and P2 of the EPs were appearing around 460 ms 
and 550 ms after the stimulus, respectively. Thus, the average peak-to-peak latency 
interval was 90 ms, which corresponds to a frequency around 5.5 Hz (1/0.180 s). 
Taken individual variability in this interval in to considerations, oscillations of the 
N2/P2 latency interval, which reflect a major part of the pain specific morphology, 
was found in the low frequency bands. Thus, decreased low frequency oscillations 
reflect decreased N2/P2 amplitudes of EPs. It has previously been shown that 
opioids decrease the N2/P2 amplitude of EPs (Chizh, Priestley, Rowbotham, & 
Schaffler, 2009; Malver et al., 2014). On the other hand, other studies reported 
unchanged amplitudes of the average EPs evoked from electrical oesophageal and 
rectal stimulation following morphine treatment (Lelic, Olesen, Gregersen, et al., 
2014; Staahl et al., 2011), and it could be speculated that morphine reduce latency 
jitter, reflected by higher average amplitudes compared to placebo treatment. 
Opioid-induced increases in high frequency oscillations of spontaneous EEG during 
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morphine treatment have also been shown (Matejcek, Pokorny, Ferber, & Klee, 
1988). As mentioned earlier in the discussion, the N2/P2 response is related to 
insula and cingulate cortex activity and other studies showed that morphine alter the 
dominant electrical activity and networks in the limbic system, where opioid 
receptor density are high (Lelic, Olesen, Brock, Staahl, & Drewes, 2012; Lelic, 
Olesen, Gregersen, et al., 2014; Staahl et al., 2011). Hence, changes in frequency 
oscillations are likely related to altered pain processing induced by morphine 
treatment.   
 
 
Blood oxygen-level dependent response 
Morphine treatment induced reduced pain-related brain activation in insular cortex, 
anterior cingulate cortex and inferior parietal cortex. This supports the above 
mentioned findings of decreased insula and cingulate cortex activity reflected in 
decreased frequency oscillations assessed by EEG. Pharmacological fMRI studies 
(both during rest and pain) reported opioids-induced changes in BOLD signal in 
several regions in the brain, see Table 3. These studies cannot be fully compared to 
the results in paper III, as they used different conditions, opioids, doses, and drugs 
were administered intravenously. Thus, they did not only measure the isolated 
analgesic effect but also activation of areas involved in sedation and reward. These 
side-effects are less pronounced after oral administration of morphine, and hence 
our findings may more specifically reflect the true analgesic effect. Becerra et al. 
reported the SI, thalamus, ACC, hypothalamus, periaqueductal gray, nucleus 
accumbens and hippocampus to be involved in the analgesic response (Becerra et 
al., 2006). Decreased pain response in pain-specific areas during remifentanil 
infusion have been reported (Wager et al., 2013; Wanigasekera et al., 2012; Wise et 
al., 2002). Furthermore, ACC and the IC have high density of opioids receptors 
(Jones et al., 1991; Petrovic et al., 2002; Willoch et al., 1999). This seems 
consistent with our findings of reduced brain response in the ACC and the IC after 
morphine treatment. A stronger effect of morphine can likely be obtained with a 
more painful stimulus intensity and a higher treatment dose, as indicated in a 
previous fMRI study in opioids showing the BOLD response to be dose-dependent 
(Upadhyay et al., 2012).  
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Table 3: Results from studies of opioid-induced changes in BOLD signal during pain and 
rest.   
Authors N Opioid Condition Results (among others) 
(Gear et al., 2013) 15 i.v. 
nalbuphine 
Rest ↓ MFC, iOFC, pcPC, superior 
temporal pole, cerebellum 
↑ occipital and temporal 
cortex, IC, Th, caudate, Hi, 
pons, cerebellum  
(Wager et al., 2013) 
 
 
21 i.v. 
remifentanil 
Pain 53% reduction of pain 
signature response 
(Khalili-Mahani et 
al., 2012) 
12 i.v. morphine Rest functional connectivity NOIs 
including prefrontal regions, 
posterior parietal areas, medial 
temporal regions, primary 
sensory, primary motor, basal 
ganglia and cerebellum 
(Upadhyay et al., 
2012) 
36 i.v and sl. 
buprenorphine 
Pain ↓ in sensorimotor/sensory-
discriminative circuitry 
↑ in limbic and mesolimbic 
circuitry 
(Wanigasekera et 
al., 2012) 
 
25 i.v. 
remifentanil 
Pain ↓ IC, ACC, basal ganglia 
(Becerra et al., 
2006) 
 
 
8 i.v. morphine Rest Regions involved in analgesia: 
↓ SI, Th, ACC, PAG ↑ Hy, 
NA, Hi  
(Wise et al., 2002) 
 
 
9 i.v. 
remifentanil 
Pain ↓ IC, ACC 
Studies are listed in a descending order based on year published. I.v.: intravenious; sl: 
sublingual; MFC: middle frontal cortex; iOFC; inferior orbitofrontal cortex; pcPC: post 
central parietal cortex; IC: insula cortex; Th: thalamus; Hi: hippocampus; NOIs: networks 
of interest; ACC: anterior cingulate cortex; PAG: periaqueductal gray; Hy:  hypothalamus; 
NA: nucleus accumbens; Hi: hippocampus. 
 
Magnetic resonance spectroscopy response 
Concentration ratios of glutamate/creatine, myoinositol/creatine, and N-
acetylaspartate/creatine were decreased during painful stimulation after morphine 
treatment. To my best knowledge, no existing literature describes MRS in opioid 
treatment in HV and more experimental studies are needed to investigate this topic 
further. Gao et al. found a decrease in glutamate and N-acetylaspartate and an 
increased level of myoinositol, and Xiang et al. reported an increase in myoinositol 
and aspartate levels and a decrease in glutamate levels (among other changes) after 
chronic morphine treatment in rats (Gao et al., 2007; Xiang et al., 2006). Otherwise 
changes in brain metabolite concentrations have been investigated in long-term 
opioids dependent subject (Haselhorst et al., 2002; Yücel et al., 2007). Yücel et al. 
THE BRAIN’S RESPONSE TO PAIN AND MORPHINE 
46
 
showed reduced N-acetylaspartate and glutamate + glutamine levels in methadone-
dependent or buprenorphine-dependent subjects and Haselhorst et al. reported 
decreased levels of N-acetylaspartate in heroin-dependent subjects. These results 
are obtained from different brain areas and cannot be compared directly with results 
in paper IV as the studies are too different in design. But, these studies indicated 
that N-acetylaspartate, glutamate and myoinositol concentrations are related to the 
physiology of pain and opioid treatment. 
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CHAPTER 6. CONCLUSIONS 
The pain system was modeled using CHEPS for heat stimulation in patients 
suffering from painful chronic pancreatitis in comparison to healthy volunteers with 
pain response being assessed electrophysiologically (with EEG). Decreased 
habituation was found for chronic pancreatitis patients and this might reflect central 
sensitisation, which has been demonstrated in previous studies. Thus, the method is 
valid to reveal altered pain processing at the electrophysiological level. To 
investigate other methods to extract more complementary information about central 
pain processing, the EEG, blood oxygen-level dependent (BOLD) and magnetic 
resonance spectroscopy (MRS) responses to pain were investigated in healthy 
volunteers. These methods showed CHEPS-induced increased activation of pain-
specific areas and changes in brain metabolites, which were comparable to previous 
studies and understandable from a pain physiology point of view. Thus, as the pain 
response can be assessed by EEG, BOLD, and MRS, these methods were also used 
to investigate the morphine-response in healthy volunteers. Morphine decreased 
low-frequency oscillations in the pain evoked EEG revealing decreased N2/P2 
amplitudes, which might reflect decreased activity in insula cortex and the anterior 
cingulate cortex. Decreased insula cortex and anterior cingulate cortex activity was 
confirmed using BOLD fMRI. MRS of the anterior cingulate cortex showed 
decreased levels of metabolite concentrations and especially decreased levels of 
glutamate and N-acetylaspartate may reflect decreased brain activity and neuronal 
metabolism. These results are in line with the high density of opioid receptors in 
insula and the anterior cingulate cortex. Overall, from the results presented in this 
thesis, this emphasise the role of insula cortex and the anterior cingulate cortex in 
pain processing as well as in morphine-treatment. More importantly, it can be 
concluded that the present methods are valid to assess the pain response and drug 
effect. As the mechanisms behind chronic pain and chronification are complex, 
knowledge obtained from the combination of more modalities and different 
methods will likely contribute to expanded understanding of these mechanisms and 
play an important role in development of new drugs and optimisation of treatment 
strategies of chronic pain.  
 
 
 
 
 
  
CHAPTER 7. FUTURE PERSPECTIVES 
The ability to assess and combine information from multiple modalities and 
techniques provides a strong tool in the investigation of pain processing and 
analgesic effects of existing drugs as well as in development of new drugs for 
treatment of chronic pain. In this thesis, three different measurements of the pain 
and morphine effect were presented. In future studies of chronic pain patients, it 
would be beneficial to include even more information such as pharmacogenomics, 
metabolomics, and structural MRI. Structural MRI can easily be obtained during 
the MRI session and allows information on neuroplastic changes in cortical 
thickness and microstructure (diffusion tensor imaging), and this can be combined 
with the functional information. Such structural and microstructural methods have 
previously been used to reveal alterations in chronic pain patients (Frøkjær et al., 
2012; Frøkjær, Olesen, et al., 2011). Other EEG and MRI measurements such as 
resting state EEG, resting state fMRI, arterial spin labeling and multi voxel 
spectroscopy are also likely to provide future supplementary information and we 
work on developing and explore these measurements. Especially combining resting 
state fMRI and diffusion tensor imaging may provide a powerful tool to understand 
brain plasticity and reorganisation of the central nervous system in chronic pain 
disorders as structural and functional changes are merged. Information from 
multiple modalities can be included in a combined analytical model to extract 
characteristics (features) of the pain and treatment response and in prediction of the 
pain and treatment response.  
     We investigated pain and morphine response by EEG, BOLD and MRS in two 
different sessions in study II, and the results from the individual studies were 
interpreted separately. One approach to obtain more information from future studies 
is the possibility to combine acquisition of more modalities simultaneously 
(“hybrid-imaging” such as MR/PET, MR/CT, MR/SPECT, PET/CT ect.). 
Furthermore, simultaneous EEG and fMRI has been recorded in several studies, all 
though this is not without technical challenges (Christmann, Koeppe, Braus, Ruf, & 
Flor, 2007; Garreffa et al., 2004; Iannetti et al., 2005). One major advantage of 
combined acquisition of more modalities is the ability of measuring the same 
neurophysiological state.  
     To further explore the mechanisms behind pain and morphine response in 
healthy volunteers (study II),  resting state EEG and resting state fMRI recordings 
were included in the study and the analyses are ongoing. The above mentioned EEG 
and MRI methods can also easily be applied in the investigation of other drugs. 
Ongoing analysis of the drug response in healthy volunteers is performed in a 
randomised, double-blinded, placebo-controlled crossover study using oxycodon 
(opioid) and venlafaxcin (antidepressant). Based on knowledge of the pain 
mechanisms behind CP pain obtained from our previous work, we use a 
combination of EEG and MRI based methods (resting state EEG, resting state 
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fMRI, MRS and structural MRI) in a randomised, double-blinded, placebo-
controlled prospective clinical trial assessing the effect of a ketamine treatment 
approach in patients with painful chronic pancreatitis. 
     As an overall and optimal goal, we aim in a future perspective to understand and 
improve treatment in chronic pain disorders and to provide personalised treatment.  
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